Set7/Set9, GST-tag (E. coli-derived) Recombinant

Catalog #
51010
$325 *
Size: 100 µg
Qty
*US Pricing only. For international pricing, please contact your local distributor.
Purchase
Description

Human recombinant SET domain containing lysine methyltransferase 7 (SETD7), or SET7/9 (GenBank Accession No. NM_030648), a.a. 52-266 (end) with N-terminal GST-tag, MW = 61 kDa, expressed in an E. coli expression system.

This product has been cited 3 times.

Synonyms
Set7/9, SETD7, KIAA1717, KMT7, SET7, SET9
Product Info
Storage and Usage
Citations3
Species
Human
Host Species/Expression System
E. coli
Purity

≥55%

Format
Aqueous buffer solution
Formulation
40 mM Tris-HCl, pH 8.0, 110 mM NaCl, 2.2 mM KCl, 3 mM DTT, 20% glycerol, and 16 mM glutathione
MW
61 kDa
Amino Acids
52–266 (end)
Specific Activity
0.58 pmol/min/µg
Genbank #
NM_030648
UniProt #
Q8WTS6
Tag(s)
N-terminal GST-tag
Background
SETD7 or SET domain containing lysine methyltransferase 7 is a lysine methyltransferase which can methylates lysine-4 (K4) in histone H3 in vitro and in vivo. Methylation of K4 in histone H3 by SETD7 and methylation of K9 in histone H3 by SUV39H1 were found to have differential effects on subsequent histone acetylation by p300. SETD7 can also methylate p53 at lys372 within the C-terminal regulatory region. Methylated p53 is restricted to the nucleus and the modification positively affects its stability. SETD7 regulates the expression of p53 target genes in a manner dependent on the p53 methylation site.
References

1. Ivanov G.S. et al., Mol. Cell. Biol. 27 (19), 6756-6769 (2007).
2. Couture J.F. et al., Nat. Struct. Mol. Biol. 13 (2), 140-146 (2006).